Literature DB >> 31041127

Poor glycemic control and posterior circulation ischemic stroke.

Junya Kuroda1, Ryu Matsuo1, Yuko Yamaguchi1, Noriko Sato1, Masahiro Kamouchi1, Jun Hata1, Yoshinobu Wakisaka1, Tetsuro Ago1, Takanari Kitazono1.   

Abstract

BACKGROUND: This study aimed at determining whether diabetes or glucose metabolism is associated with ischemic stroke in the posterior circulation.
METHODS: We included 10,245 patients with acute ischemic stroke (mean age 72.7 ± 12.5 years, men 59.5%) who were enrolled in a multicenter hospital-based stroke registry in Fukuoka, Japan, between June 2007 and August 2016. Posterior circulation ischemic stroke (PCIS) was defined as brain infarction in the territory of the posterior cerebral artery and vertebro-basilar arteries. We investigated the associations between diabetes or glycemic parameters, including plasma glucose concentrations, hemoglobin A1c, and the homeostatic model assessment of insulin resistance (HOMA-IR), and PCIS using logistic regression analysis. To improve covariate imbalance, we further evaluated associations after propensity score matching using 1:1 nearest neighbor matching and inverse probability weighting.
RESULTS: Diabetes was significantly associated with PCIS even after adjusting for multiple confounding factors (odds ratio-OR [95% confidence interval], 1.37 [1.25-1.50]). Similarly, fasting (1.07 [1.02-1.12]/SD), casual plasma glucose (1.16 [1.11-1.20]/SD) concentrations, and hemoglobin A1c (1.12 [1.08-1.17]/SD), but not HOMA-IR (1.02 [0.97-1.07]/SD), were associated with PCIS. These associations were maintained in patients with ischemic stroke because of thrombotic etiology and were unchanged even after the propensity score matching methods. In patients with diabetes, the ORs of PCIS further increased with an increase in hemoglobin A1c and the presence of microvascular complications.
CONCLUSIONS: Poor glycemic control may be associated with an increased risk of thrombotic infarction that occurs preferentially in the posterior circulation of the brain.

Entities:  

Year:  2019        PMID: 31041127      PMCID: PMC6461411          DOI: 10.1212/CPJ.0000000000000608

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  33 in total

1.  Dynamic autoregulation testing in the posterior cerebral artery.

Authors:  C Haubrich; A Wendt; R R Diehl; C Klötzsch
Journal:  Stroke       Date:  2004-02-26       Impact factor: 7.914

2.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

Review 3.  Diabetes, the metabolic syndrome, and ischemic stroke: epidemiology and possible mechanisms.

Authors:  Ellen L Air; Brett M Kissela
Journal:  Diabetes Care       Date:  2007-09-11       Impact factor: 19.112

4.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

5.  Stroke patterns, etiology, and prognosis in patients with diabetes mellitus.

Authors:  Th Karapanayiotides; B Piechowski-Jozwiak; G van Melle; J Bogousslavsky; G Devuyst
Journal:  Neurology       Date:  2004-05-11       Impact factor: 9.910

6.  Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes.

Authors:  S Sato; K Toyoda; T Uehara; N Toratani; C Yokota; H Moriwaki; H Naritomi; K Minematsu
Journal:  Neurology       Date:  2008-04-23       Impact factor: 9.910

7.  Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study.

Authors:  L Edvinsson; C Owman; N O Sjöberg
Journal:  Brain Res       Date:  1976-10-22       Impact factor: 3.252

8.  Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lori D Bash; Elizabeth Selvin; Michael Steffes; Josef Coresh; Brad C Astor
Journal:  Arch Intern Med       Date:  2008-12-08

9.  Cerebral infarction in diabetes: clinical pattern, stroke subtypes, and predictors of in-hospital mortality.

Authors:  Adrià Arboix; Antoni Rivas; Luis García-Eroles; Lourdes de Marcos; Joan Massons; Montserrat Oliveres
Journal:  BMC Neurol       Date:  2005-04-15       Impact factor: 2.474

Review 10.  Prognosis of vertebrobasilar transient ischaemic attack and minor stroke.

Authors:  Enrico Flossmann; Peter M Rothwell
Journal:  Brain       Date:  2003-07-07       Impact factor: 13.501

View more
  3 in total

1.  Stroke Risk Factors in United States: An Analysis of the 2013-2018 National Health and Nutrition Examination Survey.

Authors:  Zhouming Ren; Xinzheng Fu
Journal:  Int J Gen Med       Date:  2021-09-28

2.  Comparison of symptomatic vertebrobasilar plaques between patients with and without Diabetes Mellitus using computed tomographic angiography and vessel wall magnetic resonance imaging.

Authors:  Huan Yang; Bo Liu; Qingqing Yin; Shuai Zhang; Yelong Shen; Congshan Ji; Haipeng Wang; Yin Dong; Liangjie Lin; Ximing Wang
Journal:  Diab Vasc Dis Res       Date:  2022 Jan-Feb       Impact factor: 3.291

3.  Factors associated with two different stroke mechanisms in perforator infarctions regarding the shape of arteries.

Authors:  Sang Hee Ha; Jae-Chan Ryu; Jae-Han Bae; Sujin Koo; Jun Young Chang; Dong-Wha Kang; Sun U Kwon; Jong S Kim; Dae-Il Chang; Bum Joon Kim
Journal:  Sci Rep       Date:  2022-10-06       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.